返回
Biocure Technology Inc (BICTF) 收益
BICTF 股價走勢圖
BICTF 收益
Biocure Technology Inc
$0.01
0%
$0
收盤價：Mar 24, 16:00:00 GMT-4
$0.01
0%
$0
盤前：Mar 25, 06:17:14 GMT-4
關鍵數據
前收市價
$0.01
開盤價
$0.01
當日範圍
$0.01 - $0.07
52週區間
$0.0012 - $0.63
交易量
1.0K
平均成交量
0
股息收益率
--
每股盈餘 (TTM)
-0.02
市值
$154.4K
什麼是 BIOCURE TECHNOLOGY INC？
Biocure Technology, Inc. engages in the development and commercialization of biosimilar products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2008-03-27. The firm specializes in the development and commercialization of its own CAR T-cell therapy, targeting Chronic lymphocytic leukemia and solid tumor cancers. Additionally, the Company is developing biosimilar technologies for cancer treatment. The Company’s products include Interferon Beta, Ranibizumab and PEG-Filgrastim.
